24-hour blood pressure control - A predictor for clinical outcomes

Current Hypertension Reviews

Volumn 5, Issue 2, 2009, Pages 102-122

  Kario, Kazuomi ^a   Lowy, Adam ^b   Munk, Veronica C ^b   Annemans, Lievens ^c  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NOVARTIS PHARMA AG   (Switzerland)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

24 hour blood pressure control; Cardiovascular disease; Health economics; Hypertension; Modeling; Target organ damage

Indexed keywords

ANTIHYPERTENSIVE AGENT; NISOLDIPINE;

ARTERIAL WALL THICKNESS; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG MONITORING; EVENING DOSAGE; HUMAN; HYPERTENSION; MORBIDITY; MORNING DOSAGE; MORTALITY; PRIORITY JOURNAL; PULSE PRESSURE; REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 68549096425     PISSN: 15734021     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340209788166913     Document Type: Review

References (123)

1. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987; 5: 93-8.
2. McGrath BP. Ambulatory blood pressure monitoring. Med J Aust 2002; 176: 588-92.
3. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 2000; 35: 844-51.
4. Verdecchia P, Angeli F. How can we use the results of ambulatory blood pressure monitoring in clinical practice? Hypertension 2005; 46: 25-6.
5. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.
6. Verdecchia P, Schillaci G, Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528-36.
7. Devereux RB, Pickering TG. Relationship between the level, pattern and variability of ambulatory blood pressure and target organ damage in hypertension. J Hypertens Suppl 1991; 9: S34-8.
8. Liu JE, Roman MJ, Pini R, et al. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999; 131: 564-72.
9. Mancia G, Zanchetti A, Agabiti-Rosei E, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on ambulatory monitoring of blood pressure and lisinopril evaluation. Circulation 1997; 95: 1464-70.
10. Verdecchia P, Clement D, Fagard R, Palatini P, Parati G. Blood Pressure Monitoring. Task force III: Target-organ damage, morbidity and mortality. Blood Press Monit 1999; 4: 303-17.
11. Verdecchia P, Angeli F, Cavallini C. Ambulatory blood pressure for cardiovascular risk stratification. Circulation 2007; 115: 2091-93.
12. Mancia G, De BG, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462-1536.
13. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 2006; 354: 2368-74.
14. Mancia G, Parati G. Guiding antihypertensive treatment decisions using ambulatory blood pressure monitoring. Curr Hypertens Rep 2006; 8: 330-7.
15. Bur A, Herkner H, Vlcek M, Woisetschläger C, Derhaschnig U, Hirschl MM. Classification of blood pressure levels by ambulatory blood pressure in hypertension. Hypertension 2002; 40: 817-22.
16. Myers MG. Methods for evaluating the duration of action of once-daily antihypertensive therapy. Blood Press Monit 2003; 8: 161-3.
17. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107: 1401-6.
18. Meredith PA. ACE inhibition and AT1 receptor blockers: efficacy and duration in hypertension. Heart 2000; 84 (Suppl 1): i39-41.
19. Mancini GB, Dahlof B, Diez J. Surrogate markers for cardiovascular disease: structural markers. Circulation 2004; 109: IV22-30.
20. Sega R, Corrao G, Bombelli M, et al. Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension 2002; 39: 710-4.
21. Khattar RS, Acharya DU, Kinsey C, Senior R, Lahiri A. Longitudinal association of ambulatory pulse pressure with left ventricular mass and vascular hypertrophy in essential hypertension. J Hypertens 1997; 15: 737-43.
22. Mancia G, Parati G. Importance of smooth and sustained blood pressure control in preventing cardiovascular morbidity and mortality. Blood Press Suppl 2001; 26-32.
23. Zakopoulos NA, Ikonomidis I, Vemmos KN, et al. Twenty-four-hour heart rate and blood pressure are additive markers of left ventricular mass in hypertensive subjects. Am J Hypertens 2006; 19: 170-7.
24. Palmas W, Moran A, Pickering T, et al. Ambulatory pulse pressure and progression of urinary albumin excretion in older patients with type 2 diabetes mellitus. Hypertension 2006; 48: 301-8.
25. Zakopoulos NA, Tsivgoulis G, Barlas G, et al. Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension 2005; 45: 505-12.
26. Zakopoulos NA, Tsivgoulis G, Barlas G, et al. Impact of the time rate of blood pressure variation on left ventricular mass. J Hypertens 2006; 24: 2071-7.
27. Sander D, Kukla C, Klingelhöfer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study. Circulation 2000; 102: 1536-41.
28. Kaneda R, Kario K, Hoshide S, Umeda Y, Hoshide Y, Shimada K. Morning blood pressure hyper-reactivity is an independent predictor for hypertensive cardiac hypertrophy in a community-dwelling population. Am J Hypertens 2005; 18: 1528-33.
29. Parati G, Omboni S, Rizzoni D, Agabiti-Rosei E, Mancia G. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens 1998; 16: 1685-1691.
30. Polonia J, Amado P, Barbosa L, et al. Morning rise, morning surge and daytime variability of blood pressure and cardiovascular target organ damage. A cross-sectional study in 743 subjects. Rev Port Cardiol 2005; 24: 65-78.
31. Gosse P, Lasserre R, Minifie C, Lemetayer P, Clementy J. Blood pressure surge on rising. J Hypertens 2004; 22: 1113-8.
32. Marfella R, Siniscalchi M, Nappo F, et al. Regression of carotid atherosclerosis by control of morning blood pressure peak in newly diagnosed hypertensive patients. Am J Hypertens 2005; 18: 308-18.
33. Seo HS, Kang TS, Park S, et al. Non-dippers are associated with adverse cardiac remodeling and dysfunction (R1). Int J Cardiol 2006; 112: 171-7.
34. Cuspidi C, Meani S, Valerio C, Fusi V, Zanchetti A. Nocturnal non-dipping pattern in untreated hypertensives at different cardiovascular risk according to the 2003 ESH/ESC guidelines. Blood Press 2006; 15: 37-44.
35. Lacourciere Y, Krzesinski JM, White WB, Davidai G, Schumachere H. Sustained antihypertensive activity of telmisartan compared with valsartan. Blood Press Monit 2004; 9: 203-10.
36. White WB, Lacourciere Y, Davidai G. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period. Am J Hypertens 2004; 17: 347-53.
37. Mancia G, Giannattasio C, Failla M, Sega R, Parati G. Systolic blood pressure and pulse pressure: role of 24-h mean values and variability in the determination of organ damage. J Hypertens Suppl 1999; 17: S55-61.
38. Elliott HL. 24-hour blood pressure control: its relevance to cardiovascular outcomes and the importance of long-acting antihypertensive drugs. J Hum Hypertens 2004; 18: 539-43.
39. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens 2004; 22: 435-45.
40. White WB, Mansoor GA, Pickering TG, et al. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am J Hypertens 1999; 12: 806-14.
41. Verdecchia P, Schillaci G, Borgioni C, Gattobigio R, Ambrosio G, Porcellati C. Prevalent influence of systolic over pulse pressure on left ventricular mass in essential hypertension. Eur Heart J 2002; 23: 658-65.
42. Stergiou GS, Efstathiou SP, Argyraki CK, Gantzarou AP, Roussias LG, Mountokalakis TD. Clinic, home and ambulatory pulse pressure: comparison and reproducibility. J Hypertens 2002; 20: 1987-93.
43. Parati G, Valentini M. Prognostic relevance of blood pressure variability. Hypertension 2006; 47: 137-8.
44. Frattola A, Parati G, Cuspidi C, Albini F, Manacia G. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993; 11: 1133-7.
45. Mancia G, Parati G, Hennig M, et al. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2001; 19: 1981-9.
46. Rizzoni D, Muiesan ML, Montani G, Zulli R, Calebich S, Agabiti-Rosei E. Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens 1992; 5: 180-6.
47. Mallion JM, Baguet JP, Siche JP, Tremel F, De Gaudemaris R. Clinical value of ambulatory blood pressure monitoring. J Hypertens 1999; 17: 585-95.
48. Verdecchia P, Angeli F, Gattobigio R, Porcellati C. Ambulatory blood pressure monitoring and prognosis in the management of essential hypertension. Expert Rev Cardiovasc Ther 2003; 1: 79-89.
49. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38: 852-7.
50. White WB. Ambulatory blood pressure monitoring: dippers compared with non-dippers. Blood Press Monit 2000; 5(Suppl 1): S17-23.
51. Lurbe A, Redon J, Pascual JM, Tacons J, Alvarez V, Batlle DC. Altered blood pressure during sleep in normotensive subjects with type I diabetes. Hypertension 1993; 21: 227-35.
52. Fagard R, Staessen JA, Thijs L. The relationships between left ventricular mass and daytime and night-time blood pressures: a meta-analysis of comparative studies. J Hypertens 1995; 13: 823-9.
53. Gosse P, Schumacher H. Early morning blood pressure surge. J Clin Hypertens 2006; 8: 584-9.
54. Gosse P, Ansoborlo P, Lemetayer P, Clementy J. Left ventricular mass is better correlated with arising blood pressure than with of-24-fice or occasional blood pressure. Am J Hypertens 1997; 10: 505-10.
55. Ikeda T, Gomi T, Shibuya Y, et al. Morning rise in blood pressure is a predictor of left ventricular hypertrophy in treated hypertensive patients. Hypertens Res 2004; 27: 939-46.
56. Kario K, Pickering TG, Hoshide S, et al. Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system. Am J Hypertens 2004; 17: 668-75.
57. Kuwajima I, Mitani K, Miyao M, Suzuki Y, Kuramoto K. Cardiac implications of the morning surge in blood pressure in elderly hypertensive patients: relation to arising time. Am J Hypertens 1995; 8: 29-33.
58. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005; 46: 156-61.
59. Ohkubo T, Hozawa A, Nagai K, et al. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study. J Hypertens 2000; 18: 847-54.
60. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens 2006; 19: 243-50.
61. Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348: 2407-15.
62. Kario K, Ishikawa J, Eguchi K, et al. Sleep pulse pressure and awake mean pressure as independent predictors for stroke in older hypertensive patients. Am J Hypertens 2004; 17: 439-45.
63. Verdecchia P, Reboldi G, Porcellati C, et al. Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. J Am Coll Cardiol 2002; 39: 878-85.
64. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Pede S, Porcellati C. Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 1998; 32: 983-8.
65. Ingelsson E, Bjorklund-Bodegard K, Lind L, Arnlov J, Sundstrom J. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA 2006; 295: 2859-66.
66. Agarwal R, Andersen MJ. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int 2006; 69: 1175-80.
67. Staessen JA, Thijs L, O'Brien ET, et al. Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. Am J Hypertens 2002; 15: 835-43.
68. Verdecchia P, Angeli F, Gattobigio R, Rapicetta C, Reboldi G. Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension. Am J Hypertens 2007; 20: 154-61.
69. Pringle E, Phillips C, Thijs L, et al. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 2003; 21: 2251-7.
70. Kikuya M, Hozawa A, Ohokubo T, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000; 36: 901-6.
71. Ohkubo T, Hozawa A, Yamaguchi J, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20: 2183-9.
72. Bastos JM, Bertoquini S, Silva JA, Polonia J. Relationship between ambulatory blood pressure monitoring values and future occurrence of ischemic cerebrovascular and coronary events in hypertensive patients. Rev Port Cardiol 2006; 25: 305-16.
73. Parati G. Blood pressure variability: its measurement and significance in hypertension. J Hypertens Suppl 2005; 23: S19-25.
74. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005; 45: 142-61.
75. Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 1998; 31: 712-8.
76. Boggia J, Li Y, Thijs L, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007; 370: 1219-29.
77. Verdecchia P, Schillaci G, Reboldi G, Franklin SS, Porcellati C. Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation 2001; 103: 2579-84.
78. Inoue R, Ohkubo T, Kikuya M, et al. Predicting stroke using 4 ambulatory blood pressure monitoring-derived blood pressure indices: the Ohasama Study. Hypertension 2006; 48: 877-82.
79. Pierdomenico SD. Blood pressure variability and cardiovascular outcome in essential hypertension. Am J Hypertens 2007; 20: 162-3.
80. Cicconetti P, Morelli S, Ottaviani L, et al. Blunted nocturnal fall in blood pressure and left ventricular mass in elderly individuals with recently diagnosed isolated systolic hypertension. Am J Hypertens 2003; 16: 900-5.
81. Mousa T, el-Sayed MA, Motawea AK, Salama MA, Elhendy A. Association of blunted nighttime blood pressure dipping with coronary artery stenosis in men. Am J Hypertens 2004; 17: 977-80.
82. Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation 1990; 81: 700-2.
83. Tsivgoulis G, Vemmos KN, Zakopoulos N, et al. Association of blunted nocturnal blood pressure dip with intracerebral hemorrhage. Blood Press Monit 2005; 10: 189-95.
84. Yamamoto Y, Akiguchi I, Oiwa K, Hayashi M, Ohara T, Ozasa K. The relationship between 24-hour blood pressure readings, subcortical ischemic lesions and vascular dementia. Cerebrovasc Dis 2005; 19: 302-8.
85. Bjorklund K, Lind L, Andren B, Lithell H. The majority of nondipping men do not have increased cardiovascular risk: a population-based study. J Hypertens 2002; 20: 1501-6.
86. Fagugli RM, Quintaliani G, Pasini P, et al. Blunted nocturnal blood pressure decrease and left-ventricular mass in hypertensive hemodialysis patients. Nephron 2002; 91: 79-85.
87. Stergiou GS, Mountokalakis TD. Detection of non-dipper hypertensives in clinical practice: does it really matter? Nephrol Dial Transplant 1999; 14: 2969-70.
88. Bjorklund K, Lind L, Zethelius B, Berglund L, Lithel H. Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. J Hypertens 2004; 22: 1691-7.
89. Kario K, Shimada K. Risers and extreme-dippers of nocturnal blood pressure in hypertension: antihypertensive strategy for nocturnal blood pressure. Clin Exp Hypertens 2004; 26: 177-89.
90. Elliot WJ. Cyclic and circadian variations in cardiovascular events. Am J Hypertens 2001; 14: 291S-5.
91. Giles TD. Circadian rhythm of blood pressure and the relation to cardiovascular events. J Hypertens Suppl 2006; 24: S11-6.
92. Gosse P, Cipriano C, Bemurat L, et al. Prognostic significance of blood pressure measured on rising. J Hum Hypertens 2001; 15: 413-7.
93. Kario K, Shimada K, Pickering TG. Clinical implication of morning blood pressure surge in hypertension. J Cardiovasc Pharmacol 2003; 42(Suppl 1): S87-91.
94. Taylor RS, Drummond MF, Salkeld G, Sullivan SD. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ 2004; 329: 972-5.
95. Conway J, Boon N, Jones JV, Sleight P. Involvement of the baroreceptor reflexes in the changes in blood pressure with sleep and mental arousal. Hypertension 1983; 5: 746-8.
96. Parati G. Assessing circadian blood pressure and heart rate changes: advantages and limitations of different methods of mathematical modelling. J Hypertens 2004; 22: 2061-4.
97. Parati G, Vrijens B, Vincze G. Analysis and interpretation of 24-h blood pressure profiles: Appropriate mathematical models may yield deeper understanding. Am J Hypertens 2008; 21: 123-5.
98. Chau NP, Mallion JM, de GR, et al. Twenty-four-hour ambulatory blood pressure in shift workers. Circulation 1989; 80: 341-7.
99. Idema RN, Gelsema ES, Wenting GJ, et al. A new model for diurnal blood pressure profiling. Square wave fit compared with conventional methods. Hypertension 1992; 19: 595-605.
100. Head GA, Reid CM, Shiel LM, Jennings GL, Lukoshkova EV. Rate of morning increase in blood pressure is elevated in hypertensives. Am J Hypertens 2006; 19: 1010-7.
101. Ricketts JH, Head GA. A five-parameter logistic equation for investigating asymmetry of curvature in baroreflex studies. Am J Physiol 1999; 277: R441-54.
102. Muneta S, Kohara K, Hiwada K. Effects of benidipine hydrochloride on 24-hour blood pressure and blood pressure response to mental stress in elderly patients with essential hypertension. Int J Clin Pharmacol Ther 1999; 37: 141-7.
103. Parati G. Cardiovascular variability analysis. An insight into the pathophysiology of cardiovascular disease and the impact of treatment. With caution. Clin Auton Res 2002; 12: 4-8.
104. Ambrosioni E. Pharmacoeconomics of hypertension management: the place of combination therapy. Pharmacoeconomics 2001; 19: 337-47.
105. Atella V, Peracchi F, Depalo D, Rossetti C. Drug compliance, co-payment and health outcomes: evidence from a panel of Italian patients. Health Econ 2006; 15: 875-92.
106. Hedner T, Narkiewicz K, Kjeldsen SE. Cost-effectiveness of blood pressure measurement and hypertension follow-up. Blood Press 2006; 15: 4-5.
107. Rodriguez-Roca GC, Aonso-Moreno FJ, Garcia-Jimenez A, et al. Cost-effectiveness of ambulatory blood pressure monitoring in the follow-up of hypertension. Blood Press 2006; 15: 27-36.
108. Lorgelly P, Siatis I, Brooks A, et al. Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care? Br J Gen Pract 2003; 53: 794-6.
109. Krakoff LR. Cost-effectiveness of ambulatory blood pressure: a reanalysis. Hypertension 2006; 47: 29-34.
110. Ewald B, Pekarsky B. Cost analysis of ambulatory blood pressure monitoring in initiating antihypertensive drug treatment in Australian general practice. Med J Aust 2002; 176: 580-3.
111. McGrath BP. Ambulatory blood pressure monitoring and white coat hypertension: saving costs. Med J Aust 2002; 176: 571-2.
112. Pierdomenico SD, Mezzetti A, Lapenna D, et al. 'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heart J 1995; 16: 692-7.
113. Yarows SA, Khoury S, Sowers JR. Cost effectiveness of 24-hour ambulatory blood pressure monitoring in evaluation and treatment of essential hypertension. Am J Hypertens 1994; 7: 464-8.
114. Staessen JA, Byttebier G, Buntinx F, et al. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. JAMA 1997; 278: 1065-72.
115. Dahlof B. End-organ damge: does it really matter how we prevent it? Eur Heart J Suppl 2003; 5: F33-9.
116. Materson BJ, Preston RA. Classic therapeutic trials in hypertension. Were patients vulnerable to unsuppressed peak morning blood pressure? Am J Hypertens 1991; 4: 449S-453S.
117. Chonan K, Hashimoto J, Ohkubo T, et al. Insufficient duration of action of antihypertensive drugs mediates high blood pressure in the morning in hypertensive population: the Ohasama study. Clin Exp Hypertens 2002; 24: 261-75.
118. Hoshide Y, Kario K, Schwartz JE, Hoshide S, Pickering TG, Shimada K. Incomplete benefit of antihypertensive therapy on stroke reduction in older hypertensives with abnormal nocturnal blood pressure dipping (extreme-dippers and reverse-dippers). Am J Hypertens 2002; 15: 844-50.
119. Lacourciere Y, Poirier L, Lefebvre J. A comparative review of the efficacy of antihypertensive agents on ambulatory blood pressure. Can J Cardiol 2000; 16(9): 1155-66.
120. Neutel JM. Ambulaotry blood pressure monitoring to assess the comparative efficacy and duration of action of a novel new angiotensin II receptor blocker - telmisartan. Blood Press 2001; 10(Suppl 1): 27-32.
121. Neutel JM, Snith DHG. Evaluation of angiotensin II receptor blockers for 24-hour blood pressure control: meta-analysis of a clinical database. J Clin Hypertens 2003; 5(1): 58-63.
122. Birkenhager WH, Staessen JA. Dual inhibition of the renin system by aliskiren and valsartan. Lancet 2007; 370: 195-6.
123. Oparil S, Yarows SA, Patel S, Fang H, Zhang J, Satlin A. Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial. Lancet 2007; 370: 221-9.